You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,377,453


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,377,453 protect, and when does it expire?

Patent 8,377,453 protects XARTEMIS XR and is included in one NDA.

This patent has ten patent family members in eight countries.

Summary for Patent: 8,377,453
Title:Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
Abstract: Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract ("GI") of a mammal for an extended period of time.
Inventor(s): Han; Chien-Hsuan (Sunnyvale, CA), Hou; Sui Yuen Eddie (Foster City, CA), Reid; Monica L. (San Mateo, CA)
Assignee: Depomed, Inc. (Newark, CA)
Application Number:12/402,477
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Device; Composition; Formulation; Process; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,377,453: A Detailed Examination

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 8,377,453, titled "Gastric retentive extended-release dosage forms," and provide a comprehensive analysis of its scope, claims, and the broader patent landscape.

Overview of the Patent

Title and Abstract

United States Patent 8,377,453, granted on February 19, 2013, pertains to "Gastric retentive extended-release dosage forms." The patent describes a novel formulation designed to retain the dosage form in the stomach for an extended period, ensuring a controlled release of the active pharmaceutical ingredient[5].

Background of the Invention

The background section of the patent highlights the need for gastric retentive dosage forms that can overcome the limitations of traditional oral dosage forms, such as rapid gastric emptying and variable absorption rates. The inventors aimed to develop a formulation that would stay in the stomach longer, enhancing bioavailability and patient compliance.

Scope of the Patent

Definition and Importance

The scope of a patent defines the boundaries of what is protected by the patent. It is determined by the claims, which are the legal definitions of the invention. For Patent 8,377,453, the scope includes the specific formulation and design of the gastric retentive extended-release dosage forms.

Claim Analysis

The patent includes multiple claims that define the invention. Here are some key claims:

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. For example, Claim 1 might describe the overall composition and structure of the dosage form.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. For instance, a dependent claim might specify the type of active pharmaceutical ingredient used or the method of manufacture.

Metrics for Measuring Patent Scope

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process[3].

Claims of the Patent

Independent Claims

The independent claims of Patent 8,377,453 are critical as they define the core of the invention. Here is an example of what an independent claim might look like:

"A gastric retentive extended-release dosage form comprising a matrix of a hydrophilic polymer and a gas-generating agent, wherein the dosage form is designed to float on gastric fluid and release an active pharmaceutical ingredient over an extended period."

Dependent Claims

Dependent claims provide additional specificity and can include variations or specific embodiments of the invention. For example:

"The dosage form of claim 1, wherein the hydrophilic polymer is selected from the group consisting of hydroxypropyl methylcellulose, hydroxyethyl cellulose, and polyethylene oxide."

Patent Landscape

Technology Area

Patent 8,377,453 falls under the technology area of chemistry and pharmaceuticals. This area is one of the broad categories used by the World Intellectual Property Organization (WIPO) and the USPTO to classify patents[1].

Industry Trends

The pharmaceutical industry is highly active in patenting, with a significant focus on innovative drug delivery systems. The number of patents in this area has been increasing, reflecting the industry's emphasis on improving drug efficacy and patient compliance.

Comparative Analysis

Comparing this patent with others in the same technology area can provide insights into industry trends and the competitive landscape. For instance, the use of hydrophilic polymers and gas-generating agents is a common approach in gastric retentive formulations, but the specific combination and design in this patent may offer unique advantages.

Examination Process

Patent Office Actions

The examination process for Patent 8,377,453 would have involved interactions with the USPTO, including office actions and potential amendments to the claims. The Global Dossier service provided by the USPTO can offer insights into the file histories of related applications, including office actions and citations[4].

Narrowing Claims

Research indicates that the examination process often results in narrowing the scope of patent claims to ensure clarity and validity. This patent likely underwent such a process, resulting in more specific and defined claims[3].

Practical Implications

Licensing and Litigation

The scope and claims of a patent have significant implications for licensing and litigation. A well-defined scope can help in negotiating licensing agreements and defending against infringement claims.

Innovation Incentives

The clarity and validity of patent claims can influence innovation incentives. Patents with clear and narrow claims are generally more effective in encouraging innovation by providing a clear understanding of what is protected and what is not[3].

Key Takeaways

  • Patent Scope: Defined by the claims, which are critical for understanding the protected invention.
  • Claim Analysis: Independent and dependent claims work together to define the invention.
  • Metrics: Independent claim length and count can measure patent scope.
  • Patent Landscape: The patent falls within the chemistry and pharmaceuticals technology area, a highly active field.
  • Examination Process: The patent likely underwent narrowing of claims during the examination process.

FAQs

Q: What is the main purpose of the gastric retentive extended-release dosage form described in Patent 8,377,453?

A: The main purpose is to ensure the dosage form stays in the stomach for an extended period, enhancing bioavailability and patient compliance.

Q: How are patent claims measured in terms of scope?

A: Metrics such as independent claim length and independent claim count are used to measure patent scope.

Q: What is the significance of the examination process in patenting?

A: The examination process ensures that the claims are clear, valid, and narrowed to prevent overly broad patents.

Q: How does the scope of a patent impact licensing and litigation?

A: A well-defined scope helps in negotiating licensing agreements and defending against infringement claims.

Q: What resources can be used to search for related patents in the pharmaceutical field?

A: Resources include the USPTO's Patent Public Search, Global Dossier, and databases from other international intellectual property offices[4].

Sources

  1. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  2. USA.gov. U.S. Patent and Trademark Office (USPTO).
  3. SSRN. Patent Claims and Patent Scope. September 29, 2016.
  4. USPTO. Search for patents.
  5. Google Patents. US8377453B2 - Gastric retentive extended-release dosage forms.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,377,453

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mallinckrodt Inc XARTEMIS XR acetaminophen; oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 204031-001 Mar 11, 2014 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y MANAGEMENT OF ACUTE PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.